SLC16A1 and posterior cortical atrophy: This integrative analysis provided a potential signaling axis in which bone-secreted soluble factors regulate tumoral PKA, which, in turn, regulates PPARA, VDR, SLC16A1, GPX1 and PAPSS2 expression, leading to the metabolic rewiring of PCa cells, likely favoring disease progression.